Envista (NYSE:NVST) Stock Rating Upgraded by JPMorgan Chase & Co.

Key Points

• JPMorgan upgraded Envista from “neutral” to “overweight” and set a $32 price target, implying 16.95% upside from the prior close. The analyst consensus is “Moderate Buy,” with an average target of $29.71.
• Envista reported quarterly EPS of $0.41, exceeding the $0.34 consensus estimate, while revenue reached $730.5 million, above expectations and up 7.1% year over year.
• The stock opened at $27.36 and was trading 2.7% higher, with a $4.39 billion market capitalization. Institutional investors, including California State Teachers Retirement System, significantly increased their holdings during the second quarter.

Envista (NYSE:NVST - Get Free Report) was upgraded by research analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research note issued on Thursday, Briefing.com reports. The brokerage presently has a $32.00 price objective on the stock. JPMorgan Chase & Co.'s price target suggests a potential upside of 16.95% from the company's previous close.

A number of other research firms have also commented on NVST. Deutsche Bank Aktiengesellschaft set a $32.00 price target on Envista in a research report on Thursday. Morgan Stanley set a $23.00 price target on shares of Envista in a research report on Thursday, August 6th. BMO Capital Markets started coverage on shares of Envista in a research report on Wednesday, July 8th. They issued a "market perform" rating and a $27.00 price objective for the company. Wall Street Zen upgraded shares of Envista from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 22nd. Finally, Zacks Research upgraded Envista from a "hold" rating to a "strong-buy" rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Envista presently has a consensus rating of "Moderate Buy" and a consensus price target of $29.71.

Envista Trading Up 2.7%

NYSE:NVST opened at $27.36 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. Envista has a one year low of $18.77 and a one year high of $30.42. The company has a market cap of $4.39 billion, a PE ratio of 47.17, a PEG ratio of 1.27 and a beta of 0.86. The firm has a 50-day moving average of $27.20 and a 200-day moving average of $26.30.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company's quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts expect that Envista will post 1.53 EPS for the current fiscal year.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 8,000 shares of the business's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company's stock.

Institutional Trading of Envista

A number of large investors have recently bought and sold shares of NVST. Corient Private Wealth LP raised its stake in shares of Envista by 35.8% in the second quarter. Corient Private Wealth LP now owns 703,864 shares of the company's stock valued at $18,547,000 after buying an additional 185,687 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Envista in the 2nd quarter valued at about $992,000. California State Teachers Retirement System lifted its holdings in Envista by 2,460.3% during the second quarter. California State Teachers Retirement System now owns 4,972,429 shares of the company's stock valued at $131,024,000 after purchasing an additional 4,778,217 shares during the last quarter. AlphaGrep UK Ltd bought a new position in Envista during the second quarter worth about $338,000. Finally, Nykredit A S purchased a new position in shares of Envista in the second quarter worth about $52,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.